This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Toguchida, J. Articles by Yamamuro, T. Search for Related Content PubMed PubMed Citation Articles by Toguchida, J. Articles by Yamamuro, T.

Chromosomal Reorganization for the Expression of Recessive Mutation of Retinoblastoma Susceptibility Gene in the Development of Osteosarcoma¹

Radiation Biology Center [J. T., K. I., M. S. S., M. I.] and Department of Orthopaedic Surgery, Faculty of Medicine [J. T., M. S., Y. K., T. Y.], Kyoto University, Yoshida-konoecho, Sakyo-ku, Kyoto 606, Japan

Recent evidence indicates that the mutation of retinoblastoma susceptibility (RB) gene is also involved in the development of osteosarcoma. We studied 30 cases of osteosarcoma for the structural anomalies of the RB gene by Southern hybridization analysis with cDNA probes of the RB gene. Thirteen cases (43%) showed structural anomalies of the RB gene. They included the total or partial deletion, or rearrangement of the RB gene; seven with homozygous deletions and six with hemizygous deletions or rearrangements. By the use of restriction fragment length polymorphism fragments as chromosome markers, those seven tumors having homozygous deletions and four of six tumors having hemizygous anomalies showed the loss of heterozygosity at other loci on chromosome 13. Among those tumors with no apparent structural changes of the RB gene, seven cases showed the loss of heterozygosity on chromosome 13, and altogether the loss of heterozygosity by either homozygosity or hemizygosity was found in 18 (64%) of 28 informative cases. The loss of heterozygosity was also found for nine of 10 other chromosomes, of which chromosome 17 showed the highest frequency (77%). The tumors with loss of chromosome 13 alleles also showed additional losses of alleles on other chromosomes, while tumors retaining heterozygosity of chromosome 13 also retained heterozygosity at the informative loci on other chromosomes. Southern hybridization and karyotype analysis in some selected cases suggest that the concerted loss of heterozygosity at multiple loci may be a consequence of the polyploidization-segregation process.

¹ Supported in part by grants from the Ministry of Education, Science, and Culture, and the Ministry of Health and Welfare, Japan.

² To whom requests for reprints should be addressed.

Received 1/19/88. Revised 4/12/88. Accepted 4/19/88.

This article has been cited by other articles:

				G. P. Nielsen, K. L. Burns, A. E. Rosenberg, and D. N. Louis CDKN2A Gene Deletions and Loss of p16 Expression Occur in Osteosarcomas That Lack RB Alterations Am. J. Pathol., July 1, 1998; 153(1): 159 - 163. [Abstract] [Full Text] [PDF]

				S. Baker, S Markowitz, E. Fearon, J. Willson, and B Vogelstein Suppression of human colorectal carcinoma cell growth by wild-type p53 Science, August 24, 1990; 249(4971): 912 - 915. [Abstract] [PDF]

				R Bookstein, J. Shew, P. Chen, P Scully, and W. Lee Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene Science, February 9, 1990; 247(4943): 712 - 715. [Abstract] [PDF]

				R Sager Tumor suppressor genes: the puzzle and the promise Science, December 15, 1989; 246(4936): 1406 - 1412. [Abstract] [PDF]

				S. Baker, E. Fearon, J. Nigro, Hamilton SR, A. Preisinger, J. Jessup, P vanTuinen, D. Ledbetter, D. Barker, Y Nakamura, et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas Science, April 14, 1989; 244(4901): 217 - 221. [Abstract] [PDF]

				H. Huang, J. Yee, J. Shew, P. Chen, R Bookstein, T Friedmann, E. Lee, and W. Lee Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells Science, December 16, 1988; 242(4885): 1563 - 1566. [Abstract] [PDF]